-
Mashup Score: 0Workplace-based primary prevention intervention reduces incidence of hypertension: a post hoc analysis of cluster randomized controlled study - BMC Medicine - 10 month(s) ago
Background A workplace-based primary prevention intervention be an effective approach to reducing the incidence of hypertension (HTN). However, few studies to date have addressed the effect among the Chinese working population. We assessed the effect of a workplace-based multicomponent prevention interventions program for cardiovascular disease on reducing the occurrence of HTN through…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 3ESC 365 - The cardiology knowledge hub - 1 year(s) ago
Check out the cardiology knowledge from European Society of Cardiology
Source: esc365.escardio.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
On the next #ESCTVToday - from 23 March - get the latest on #PrimaryPrevention in the elderly as well as acute and long-term treatment of pulmonary embolism. Sign up to get a reminder before each episode 👉 https://t.co/mWrbOaDB0o #cardiotwitter #medtwitter https://t.co/ZqM9NN8Yjr
-
-
Mashup Score: 3
The initiation of statins for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) remains a debated subject, despite decades worth of clinical trial data demonstrating efficacy, effectiveness, and safety. Statin therapy, in addition to blood pressure-lowering drugs and efforts to reduce cigarette smoking, was a key component of the preventive cardiology renaissance that…
Source: AtherosclerosisCategories: Cardiologists, Latest HeadlinesTweet-
RT @BrezanSimonMD: Endorsement of early #statins etc therapy for the #primaryprevention of #ASCVD https://t.co/bywGBuwXG1 https://t.co/O5…
-
-
Mashup Score: 17Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes: - 2 year(s) ago
Abstract Background The role of aspirin in reducing lipoprotein(a)-mediated atherothrombotic events in primary prevention is not established. Objectives This study sought to assess whether low-dose…
Categories: Cardiologists, Latest HeadlinesTweet-
#Aspirin for #PrimaryPrevention of Cardiovascular Events in Relation to Lipoprotein(a)genotypes https://t.co/EDjBCTQ9vV
-
Delighted to contribute to this paper in ASPREE led by @PaulLacaze & @Lpa_Doc. Our @JACCJournals study shows that a common LPA SNP (rs3798220) may identify individuals who benefit from primary prevention aspirin https://t.co/NilqObrYZV [1/3] https://t.co/O0R1GOR9Z6 https://t.co/2qWqfC4G9r
-
-
Mashup Score: 1
This systematic review to support the 2022 US Preventive Services Task Force Recommendation Statement on statin use for prevention of cardiovascular disease (CVD) summarizes published evidence on the benefits and harms of statin use for the primary prevention of CVD in adults at increased CVD risk…
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
USPSTF Evidence Review: #Statins for #PrimaryPrevention of Cardiovascular Disease in Adults https://t.co/pO1zSzXfPq
-
-
Mashup Score: 2
The U.S. Preventive Services Task Force’s new recommendation statement on the use of statin therapy for primary prevention in adults aged 40 to 75 years with no history of CVD is similar to its 2016 recommendations.The USPSTF continues to recommend statins for the primary prevention of CVD in patients aged 40 to 75 years with at least one CVD risk factor and 10% or greater 10-year risk for
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The U.S. Preventive Services Task Force’s new recommendation statement on the use of #statintherapy for #primaryprevention in adults aged 40 to 75 years with no history of CVD is similar to its 2016 recommendations @TuftsMedicalCtr #USPSTF #CardioTwitter https://t.co/UUAt5QeISk
-
-
Mashup Score: 3Lipid-lowering therapies underused for primary CVD prevention - 2 year(s) ago
In a cohort of more than 400,000 patients at high risk for CVD requiring primary prevention, less than half were taking appropriately dosed statins and less than 10% were taking nonstatin lipid-lowering therapies, researchers reported. For an abstract presented at the National Lipid Association Scientific Sessions, Ahmed A. Kolkailah, MD, cardiovascular medicine fellow at the University of Texas
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
In a cohort of > 400K high risk patients requiring #primaryprevention, less than half were taking appropriately dosed statins and less than 10% were taking nonstatin lipid-lowering therapies @AKolkailah @UTSWNews @nationallipid #NLASessions #CardioTwitter https://t.co/V9a78ZNkCu
-
-
Mashup Score: 1
The U.S. Preventive Services Task Force recommended statins for the primary prevention of CVD in patients aged 40 to 75 years with at least one CVD risk factor and 10% or greater 10-year risk for CVD.The draft recommendation is consistent with the 2016 USPSTF recommendation statement on statins for primary CVD prevention.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The #USPSTF recommended #statins for the #primaryprevention of CVD in patients aged 40 to 75 years with at least one CVD risk factor and 10% or greater 10-year risk for CVD @TuftsMedicalCtr #Cardiotwitter https://t.co/EkjRJrJoDe
-
-
Mashup Score: 1
The stroke burden continues to grow across the globe, disproportionally affecting developing countries. This burden cannot be effectively halted and reversed without effective and widely implemented
Source: StrokeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#ISC22 Current knowledge on #DigitalTechnology for primordial and primary #stroke and cardiovascular disease prevention #DigitalHealth #PrimaryPrevention @FeiginValery @sheilambrasil @mayowaoowolabi @AHAScience https://t.co/qEQBpFpUhV https://t.co/h1ObmLvn0N
-
-
Mashup Score: 5Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial - 3 year(s) ago
Background and Purpose: The HOPE-3 trial (Heart Outcomes Prevention Evaluation–3) found that antihypertensive therapy combined with a statin reduced first stroke among people at intermediate cardiova
Source: StrokeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#STROKE #CMEavailable #Statin and Antihypertensive therapy was associated with reduced stroke risk among individuals with intermediate cardiovascular risk #PrimaryPrevention #HOPE3 trial https://t.co/r2LrmGGlgY @SRSMcMasterU @PHRIresearch https://t.co/LSJmiBgwVP
-
#Posthoc #RCT analysis reveals that #workplace-based #PrimaryPrevention intervention reduces incidence of #hypertension. n= >24,000 #Chinese workers randomized to 2-y intervention/control for improving #cardiovascular health. Link - https://t.co/O2vviFQQuW ChiCTR-ECS-14004641 https://t.co/rJmb4F7HdO